Push release MHRA approves GLP –one receptor agonist semaglutide to lessen chance of serious coronary heart troubles in obese or overweight adults Semaglutide is the main weight reduction drug accredited in the united kingdom being a preventative cure for those with set up cardiovascular diseasePeople today taking Wegovy or Mounjaro commonly begi… Read More